Skip to content
Tenfell
Awarded contract
Published 08 Apr 2024

CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

Key facts

Contract value
£46,600,000
Awarded
11 Mar 2024
Contract starts
01 Mar 2024
Contract ends
28 Feb 2025
Procedure
Open procedure (above threshold)

Awarded to 2 suppliers

SupplierValue
FRESENIUS KABI LIMITED£46,600,000
Roche Products Ltd£46,600,000

Description

Project Title: NHS National Framework for Tocilizumab - March 2024

Offer reference number: CM/PHR/23/5702

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Categories (CPV)

Similar open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.